Literature DB >> 11751690

The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator.

E Rao1, R J Blaschke, A Marchini, B Niesler, M Burnett, G A Rappold.   

Abstract

Functional impairment of the human homeobox gene SHOX causes short stature and Madelung deformity in Leri-Weill syndrome (LWS) and has recently been implicated in additional skeletal malformations frequently observed in Turner syndrome. To enhance our understanding of the underlying mechanism of action, we have established a cell culture model consisting of four stably transfected cell lines and analysed the functional properties of the SHOX protein on a molecular level. Results show that the SHOX-encoded protein is located exclusively within the nucleus of a variety of cell lines, including U2Os, HEK293, COS7 and NIH 3T3 cells. In contrast to this cell-type independent nuclear translocation, the transactivating potential of the SHOX protein on different luciferase reporter constructs was observed only in the osteogenic cell line U2Os. Since C-terminally truncated forms of SHOX lead to LWS and idiopathic short stature, we have compared the activity of wild-type and truncated SHOX proteins. Interestingly, C-terminally truncated SHOX proteins are inactive with regards to target gene activation. These results for the first time provide an explanation of SHOX-related phenotypes on a molecular level and suggest the existence of qualitative trait loci modulating SHOX activity in a cell-type specific manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751690     DOI: 10.1093/hmg/10.26.3083

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3' region: implication for the downstream enhancer.

Authors:  Maki Fukami; Fumiko Kato; Toshihiro Tajima; Susumu Yokoya; Tsutomu Ogata
Journal:  Am J Hum Genet       Date:  2006-01       Impact factor: 11.025

2.  Rare pseudoautosomal copy-number variations involving SHOX and/or its flanking regions in individuals with and without short stature.

Authors:  Maki Fukami; Yasuhiro Naiki; Koji Muroya; Takashi Hamajima; Shun Soneda; Reiko Horikawa; Tomoko Jinno; Momori Katsumi; Akie Nakamura; Yumi Asakura; Masanori Adachi; Tsutomu Ogata; Susumu Kanzaki
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

Review 3.  Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region.

Authors:  Sara Benito-Sanz; Alberta Belinchon-Martínez; Miriam Aza-Carmona; Carolina de la Torre; Celine Huber; Isabel González-Casado; Judith L Ross; N Simon Thomas; Andrew R Zinn; Valerie Cormier-Daire; Karen E Heath
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

4.  A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.

Authors:  Sara Benito-Sanz; N Simon Thomas; Céline Huber; Celine Huber; Darya Gorbenko del Blanco; Darya Gorbenko Del Blanco; Miriam Aza-Carmona; John A Crolla; Vivienne Maloney; Gudrun Rappold; Jesús Argente; Jesus Argente; Angel Campos-Barros; Valérie Cormier-Daire; Valerie Cormier-Daire; Karen E Heath
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

5.  Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.

Authors:  Gudrun Rappold; Werner F Blum; Elena P Shavrikova; Brenda J Crowe; Ralph Roeth; Charmian A Quigley; Judith L Ross; Beate Niesler
Journal:  J Med Genet       Date:  2006-12-20       Impact factor: 6.318

6.  Identification of a Gypsy SHOX mutation (p.A170P) in Léri-Weill dyschondrosteosis and Langer mesomelic dysplasia.

Authors:  Verónica Barca-Tierno; Miriam Aza-Carmona; Eva Barroso; Damia Heine-Suner; Dimitar Azmanov; Jordi Rosell; Begoña Ezquieta; Lucia Sentchordi Montané; Teresa Vendrell; Jaime Cruz; Fernando Santos; José Ignacio Rodríguez; Jesús Pozo; Jesús Argente; Luba Kalaydjieva; Ricardo Gracía; Angel Campos-Barros; Sara Benito-Sanz; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2011-06-29       Impact factor: 4.246

7.  Functional redundancy between human SHOX and mouse Shox2 genes in the regulation of sinoatrial node formation and pacemaking function.

Authors:  Hongbing Liu; Chao-Hui Chen; Ramón A Espinoza-Lewis; Zhen Jiao; Ivana Sheu; Xuefeng Hu; Minkui Lin; Yanding Zhang; YiPing Chen
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

8.  Shox2 is required for chondrocyte proliferation and maturation in proximal limb skeleton.

Authors:  Ling Yu; Hongbing Liu; Mingquan Yan; Jing Yang; Fanxin Long; Ken Muneoka; YiPing Chen
Journal:  Dev Biol       Date:  2007-04-01       Impact factor: 3.582

9.  Characterization of a novel human HMBOX1 splicing variant lacking the homeodomain and with attenuated transcription repressor activity.

Authors:  Mingjun Zhang; Shuai Chen; Qiang Li; Yichen Ling; Jie Zhang; Long Yu
Journal:  Mol Biol Rep       Date:  2009-09-15       Impact factor: 2.316

10.  Recombinant human growth hormone in the treatment of Turner syndrome.

Authors:  Bessie E Spiliotis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.